Título: Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma
Autor: Richard J. Buka
Sinopse: Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine. Table of Contents: DLBCL: an overview CAR T cells CAR T-cell products Delivering CAR T-cell therapy and managing patient expectations CAR T-cell therapy-related toxicities
Contexto da obra
Quando a classificação é mais ampla, o contexto do livro costuma depender ainda mais de autoria, tema e edição. “Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma”, de Richard J. Buka, publicado pela editora Karger Medical and Scientific Publishers, em 2021 e com 95 páginas, integra a categoria Livros Variados. Por isso, autoria, edição e tema acabam tendo ainda mais peso na forma de apresentar o livro.
Editora: Karger Medical and Scientific Publishers
Páginas: 95
Ano: 2021
Edição:
Linguagem: en
ISBN: 3318070246
ISBN13: 9783318070248
